Authors


Kavita Patel, MD, MSHS

Latest:

Understanding and Improving Value Frameworks With Real-World Patient Outcomes

New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.


Collin G. Wolf, BS

Latest:

Pricing of Monoclonal Antibody Therapies: Higher If Used for Cancer?

The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.


Stephen A. Hart, MD

Latest:

Health Insurance and Racial Disparities in Pulmonary Hypertension Outcomes

In a multicenter cohort of patients with newly diagnosed pulmonary hypertension, increased risk for mortality among African Americans was no longer observed after adjusting for insurance status.





Jennifer J. Godden, PharmD

Latest:

Implementing an Oncology Precision Medicine Clinic in a Large Community Health System

Precision medicine is increasingly being utilized in oncology. Aurora Health Care has implemented Syapse software to integrate molecular data into the electronic health record to accommodate precision medicine findings.




Marco Campioni, PhD

Latest:

Cost Per Response Analysis of Strategies for Chronic Immune Thrombocytopenia

This decision tree model estimates the cost per response and incremental cost per additional responder for romiplostim, eltrombopag, and “watch and rescue” for immune thrombocytopenia.






Alan Garber, MD, PhD

Latest:

Treatment of Diabetes Mellitus: The Urgent Need for Multifactorial Interventions

The pandemic of type 2 diabetes mellitus requires implementation of multifactorial interventions by clinicians for individual patients and policy makers for the health of the general public.


Jon Rasmussen, PharmD

Latest:

Positive Predictive Values of ICD-9 Codes to Identify Patients With Stroke or TIA

This study determined that ICD-9 codes 433.X1, 434.XX, and V12.54 had positive predictive values >90%, and may be used to focus care on stroke patients.







Elizabeth Ann Stringer, PhD

Latest:

Medical Utilization Surrounding Initial Opioid-Related Diagnoses by Coding Method

Medical utilization profiles of commercially insured members with opioid-related disorders differ depending on the code used to document the initial diagnosis in administrative claims.


Allison R. Mitchinson, MPH

Latest:

Management of Chronic Noncancer Pain by VA Primary Care Providers: When Is Pain Control a Priority?

Additional training opportunities for primary care physicians and better use of ancillary services may be needed to further improve care for chronic pain patients.


Clive M. Brown, MBBS, MPH, MSc

Latest:

The Economic Impact of an Urban Asthma Management Program

An asthma disease management program reduced medical services utilization for urban children and had a potentially positive return on investment for Medicaid managed care plans.



Alberico Luigi Catapano, PhD

Latest:

Assessment and Potential Determinants of Compliance and Persistence to Antiosteoporosis Therapy in Italy

This analysis of antiosteoporosis therapy shows that 75% of patients have inadequate drug coverage and that adherence is strongly associated with age and administration regimen.




Mark Tyson, MD

Latest:

The Influence of Provider Characteristics and Market Forces on Response to Financial Incentives

We determine a specialist physician phenotype responsive to financial incentives that may be leveraged to identify physicians and markets well-suited for participation in alternative payment models.


Diane Orenstein, PhD

Latest:

State-Level Projections of Cancer-Related Medical Care Costs: 2010 to 2020

State-level estimates of the number of people treated for cancer and the average cost of their treatment by state from 2010 through 2020.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo